First-in-Human Study of RO7812653
BP45770
Phase 1 other active
Quick answer
First-in-Human Study of RO7812653 for Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairment due to AD, or probable AD dementia) is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Early Symptomatic Alzheimer’s Disease (eAD), (Mild Cognitive Impairment due to AD, or probable AD dementia)
- Phase
- Phase 1
- Modality
- other
- Status
- active